ZEISS Launches AI-Driven Research Data Platform

ZEISS has announced the introduction of its new ZEISS Research Data Platform (ZEISS RDP)—a cloud-based, AI-driven solution designed to transform workflows in ophthalmic research. A full unveiling of the platform is scheduled for the upcoming ARVO meeting.

Strategic Focus on Data-Centric Innovation in Ophthalmology

In a press release, Euan S. Thomson, PhD, Head of the Digital Business Unit for ZEISS Medical Technology, highlighted the significance of the launch:

“The future of healthcare is in the data. At ZEISS, we are delivering digital innovation to help shape the future of ophthalmology, investing in research methods that empower clinicians and researchers in balancing their clinical care and research requirements. The introduction of the ZEISS RDP reflects our commitment to advancing ophthalmic care through smarter, AI-powered tools.”

Platform Capabilities: Seamless Integration and AI-Driven Insights

According to ZEISS, the ZEISS RDP is designed to enable seamless integration of clinical and research data, helping clinicians and scientists accelerate discovery and streamline ophthalmic research.

Key features of the ZEISS RDP include:

• The ability to translate research hypotheses into quantifiable biomarkers

• Tools to train user-developed algorithms and let AI automate complex, time-consuming data analysis

• Aggregation of diverse datasets and formats from multiple sources

• A streamlined, end-to-end research workflow to support faster and more robust findings

Commercial Rollout Planned for 2025

Following a successful pilot phase, ZEISS has announced plans to launch the ZEISS Research Data Platform in select countries throughout 2025, signaling a broader commitment to digital innovation in the ophthalmic research space.